Improvement of medication adherence for desmopressin by adjusting the prescription dosage in male patients with overactive bladder: A claims database analysis
Neurourology and Urodynamics · 2024
DOI: 10.1002/nau.25541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2024. Verfasst von Kazuna Tsubouchi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Deamino Arginine Vasopressin, Nocturia, Antidiuretic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Objectives
Desmopressin is widely used for nocturia in patients with nocturnal polyuria. We investigated the continuation rate and adherence for desmopressin in patients with overactive bladder and nocturia using a claims database and evaluated factors that improved adherence.
Methods
Patients with nocturia in a Japanese claims database who started desmopressin between September 2019 and July 2021 were evaluated. Drug persistence was assessed using the Kaplan–Meier method for initial prescription of desmopressin. The proportion of days covered (PDC) was also evaluated among patients with prescription persistence. Multivariate analysis was performed using logistic regression analysis to identify factors predicting adherence to desmopressin.
Results
The study included 72,888 patients entered into Japan Medical Data Center (JMDC) database between September 2019 and July 2021. For the 236 patients prescribed desmopressin formulations, mean prescription duration was 114 days. Among the total cases, 90 (38.1%) cases were prescribed only once, mean PDC was 0.60, and the number of high‐adherence patients (PDC ≥ 0.80) was 108 (45.8%). Desmopressin prescription doses were fixed in 216 patients and adjusted in 20 patients. Multivariate analysis identified prescription dose adjustment for desmopressin as significantly associated with high PDC.
Conclusion
Desmopressin showed a 38% dropout rate after the first dose. However, high medication continuation and high medication adherence rates (PDC) could be maintained with prescription adjustments. Careful patient monitoring and appropriate adjustment of the desmopressin dosage appear to be important factors in improving nocturia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
- Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Zitieren
APA
Tsubouchi, K., Maeda, T., Emoto, T., Aoyagi, C., Matsuoka, W., Yamazaki, F., Nakagawa, C., Fukuhara, Y., Tominaga, K., Gunge, N., Miyazaki, T., Okabe, Y., Matsuzaki, H., Nakamura, N., Arima, H., & Haga, N. (2024). Improvement of medication adherence for desmopressin by adjusting the prescription dosage in male patients with overactive bladder: A claims database analysis. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25541
Vancouver
Tsubouchi K, Maeda T, Emoto T, Aoyagi C, Matsuoka W, Yamazaki F, et al. Improvement of medication adherence for desmopressin by adjusting the prescription dosage in male patients with overactive bladder: A claims database analysis. Neurourology and Urodynamics. 2024. doi:10.1002/nau.25541
BibTeX
@article{Tsubouchi2024,
author = {Tsubouchi, Kazuna and Maeda, Toshiki and Emoto, Taiki and Aoyagi, Chikao and Matsuoka, Wataru and Yamazaki, Fumihiro and Nakagawa, Chizuru and Fukuhara, Yuichiro and Tominaga, Kosuke and Gunge, Naotaka and Miyazaki, Takeshi and Okabe, Yu and Matsuzaki, Hiroshi and Nakamura, Nobuyuki and Arima, Hisatomi and Haga, Nobuhiro},
title = {Improvement of medication adherence for desmopressin by adjusting the prescription dosage in male patients with overactive bladder: A claims database analysis},
journal = {Neurourology and Urodynamics},
year = {2024},
doi = {10.1002/nau.25541}
}
EUVIMED